---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-065782"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2025-07-03T23:59:59+00:00"
generated_at: "2026-05-18T09:26:20.280760+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ReShape loans $200K to Vyome at 8% to fund merger-related expenses

## Summary
- ReShape (RSLS) issued a $200,000 promissory note to Vyome Therapeutics, bearing 8.0% interest per annum.
- Proceeds used for working capital and legal/accounting expenses related to the pending merger under July 8, 2024 agreement.
- Note matures on September 30, 2025; if merger closes before then, principal and interest become ReShape net cash.
- If merger fails due to Concurrent Financing Default, note becomes senior secured debt of Vyome.
- Termination fee reduced by outstanding principal and interest under this note and a prior April 15, 2025 note.

## SEC filing metadata
- accession: 0001104659-25-065782
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2025-07-03T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000110465925065782/0001104659-25-065782-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000110465925065782/tm2519769d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-065782
- JSON: https://secwatch.observer/filing/0001104659-25-065782.json
- Plain text: https://secwatch.observer/filing/0001104659-25-065782.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.